SCHEMBL22632085

SCHEMBL22632085

CCOC(=O)Nc1ccc2c(CCNC)cc(=O)oc2c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.69
▸ HPGD P15428 7/20 0.69
▸ KDM4E B2RXH2 6/20 0.69
▸ NPC1 O15118 4/20 0.69
▸ HSD17B10 Q99714 4/20 0.69
▸ RAB9A P51151 3/20 0.69
▸ SMN1; SMN2 Q16637 2/20 0.69
▸ RXFP1 Q9HBX9 1/20 0.62
▸ POLB P06746 3/20 0.60
▸ GAA P10253 2/20 0.60
▸ L3MBTL1 Q9Y468 2/20 0.58
▸ CASP3 P42574 1/20 0.57
▸ SENP8 Q96LD8 1/20 0.57
▸ SENP7 Q9BQF6 1/20 0.57
▸ SENP6 Q9GZR1 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.55
▸ USP2 O75604 1/20 0.55
▸ SLC18A1 P54219 1/20 0.51
▸ SLC18A2 Q05940 1/20 0.51
▸ CA12 O43570 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22632089 0.89 ALDH1A1 (0.67) ALDH1A1HPGDKDM4ENPC1HSD17B10
SCHEMBL24623222 0.88 HPGD (0.65) ALDH1A1HPGDKDM4ENPC1HSD17B10
SCHEMBL24623218 0.86 ALDH1A1 (0.63) ALDH1A1HPGDKDM4ENPC1HSD17B10
SCHEMBL6227542 0.85 ALDH1A1 (0.74) ALDH1A1HPGDKDM4ENPC1HSD17B10
SCHEMBL12987100 0.82 ALDH1A1 (1.00) ALDH1A1HPGDKDM4ENPC1HSD17B10
SCHEMBL24623271 0.78 POLB (0.53) ALDH1A1HPGDKDM4ENPC1HSD17B10
SCHEMBL30228151 0.76 HPGD (0.73) ALDH1A1HPGDKDM4ENPC1HSD17B10
SCHEMBL22632088 0.74 SLC18A1 (0.54) ALDH1A1HPGDKDM4EHSD17B10RXFP1
SCHEMBL22632087 0.73 CYP2D6 (0.76) ALDH1A1HPGDKDM4EHSD17B10GAA
SCHEMBL22632227 0.73 SLC18A1 (0.59) ALDH1A1HPGDKDM4EHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020223174-A1 COUMARIN-MODIFIED ANDROGENS FOR THE TREATMENT OF PROSTATE CANCER HEALTH RESEARCH, INC. (US) 2020-11-05 — — WO disclosed
Send feedback